Sq-NSCLC
Showing 1 - 25 of 3,586
Squamous NSCLC Trial in Jinan ("Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin")
Recruiting
- Squamous Non-small Cell Lung Cancer
- "Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin"
-
Jinan, Shandong, China
- +1 more
Feb 14, 2022
Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)
Active, not recruiting
- Non Small Cell Lung Cancer
-
Santiago De Compostela, A Coruña, Spain
- +29 more
Sep 21, 2022
NSCLC Trial in Worldwide (Nivolumab)
Completed
- Non-Small Cell Lung Cancer
-
Wels, Oberösterreich, Austria
- +89 more
Oct 17, 2022
Advanced Solid Tumors Trial in Australia, China (Sitravatinib)
Completed
- Advanced Solid Tumors
-
Blacktown, New South Wales, Australia
- +16 more
Jan 10, 2023
NSCLC Trial in Worldwide (RO7247669, Pembrolizumab, Paclitaxel)
Recruiting
- Non-small Cell Lung Cancer
- RO7247669
- +4 more
-
Benowa, Queensland, Australia
- +6 more
Mar 16, 2023
Squamous NSCLC, Non-squamous NSCLC Trial in Brazil, Canada (Nivolumab)
No longer available
- Squamous Non-Small Cell Lung Cancer
- Non-squamous Non-Small Cell Lung Cancer
-
Salvador, Bahia, Brazil
- +49 more
Nov 25, 2020
Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,
Recruiting
- Lung Non-Small Cell Squamous Carcinoma
- Stage IV Lung Cancer AJCC v8
- Berzosertib
- +6 more
-
Los Angeles, California
- +34 more
Jan 20, 2023
NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +3 more
- Montanide (Registered Trademark) ISA-51 VG Adjuvant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Monitor Lung Cancer Patients Activity And Assess Performance
Recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- Actigraphy device (wearable) and mobile application
-
Alcorcon, Madrid, Spain
- +10 more
Jan 13, 2023
Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)
Recruiting
- Non Small Cell Lung Cancer
- quaratusugene ozeplasmid
- +3 more
-
Tampa, Florida
- +2 more
Sep 12, 2022
Burns Trial in Riyadh (Enoxaparin 40 mg q24 hours, Enoxaparin 30 mg q12 hours, Unfractionated heparin 5000 U q8 hours)
Completed
- Burns
- Enoxaparin 40 mg q24 hours
- +2 more
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical City
Dec 17, 2022
Rhinitis, Allergic, Seasonal Trial in Lund, Stockholm (ALK Diluent, ALK Alutard SQ 5-grasses or ALK Alutard Birch)
Completed
- Rhinitis, Allergic, Seasonal
- ALK Diluent
- ALK Alutard SQ 5-grasses or ALK Alutard Birch
-
Lund, Sweden
- +1 more
Jun 22, 2022
Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC)
Completed
- Non Small Cell Lung Cancer Squamous (NSCLC-Sq)
- +5 more
-
Huntersville, North Carolina
- +2 more
Dec 27, 2019
SQ Sublingual Immunotherapy-Tablets vs. Controls in Allergic
Active, not recruiting
- Allergy
- +2 more
- SQ SLIT-tablet
-
Hørsholm, Copenhagen, DenmarkALK
Jul 25, 2022
Healthy Trial in Cypress (CD388 Injection, Saline )
Recruiting
- Healthy
- CD388 Injection
- Saline placebo
-
Cypress, CaliforniaAltasciences Clinical Los Angeles, Inc.
Jan 18, 2023
Yellow Fever Vaccination Reaction Trial in Frederick (Yellow Fever Vaccine)
Active, not recruiting
- Yellow Fever Vaccination Reaction
- Yellow Fever Vaccine
-
Frederick, MarylandUnited States Army Medical Research Institute of Infectious Dise
May 17, 2022
Healthy Women, Female Contraception Trial in United States (levonorgestrel butanoate (LB) injection)
Recruiting
- Healthy Women
- Female Contraception
- levonorgestrel butanoate (LB) injection
-
Davis, California
- +6 more
Jan 31, 2022
S-ICD® System Post Approval Study
Completed
- Primary Prevention of Sudden Cardiac Arrest
- Secondary Prevention of Sudden Cardiac Arrest
- S-ICD System
-
Huntsville, Alabama
- +86 more
May 16, 2022
Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)
Not yet recruiting
- Lung Cancer
- Sacituzumab Govitecan
- Pembrolizumab
- (no location specified)
Sep 20, 2023
Advanced Lung Adenocarcinoma Trial (TCM Formula, Placebo)
Completed
- Advanced Lung Adenocarcinoma
- TCM Formula
- Placebo
- (no location specified)
Jan 9, 2022
Using Urine Samples to Identify Lung Cancer
Recruiting
- Non Small Cell Lung Cancer
- urine sample
-
Basking Ridge, New Jersey
- +6 more
Sep 5, 2023
NSCLC, NSCLC, PD-1 Trial in Beijing (F520, Pemetrexed, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- +2 more
- F520
- +3 more
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Feb 22, 2023
Functional Mitral Regurgitation Trial in Shenyang (SQ-Kyrin Transcatheter Mitral Valve Repair System)
Active, not recruiting
- Functional Mitral Regurgitation
- SQ-Kyrin Transcatheter Mitral Valve Repair System
-
Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command, PLA
Aug 4, 2023